Sickle cell crisis in a patient receiving capecitabine chemotherapy.
Lee
C
C
Saunders
M
M
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D000755:Anemia, Sickle Cell / Q000139:chemically induced* / Q000188:drug therapy; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D000069287:Capecitabine; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000139:chemically induced
D000972:Antineoplastic Agents, Phytogenic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil